Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Calderone C, Taylor JM. Urothelial cancer of the bladder: treatment of early stage disease. Handb Prostate Cancer Genitourin Malig. 2017. p. 157.
2. Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74:784–95.
3. Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update. Eur Urol. 2019;76:639–57 This paper describes the current and updated European Association of Urology guidelines for diagnosis and management of non-muscle-invasive bladder cancer.
4. Howlander N, Noone A, Krapcho M, Breast A, Yu M, Ruhl J, et al. SEER cancer statistics review, 1975-2017 [Internet]. Cronin K, editor. National Cancer Institute, Bethesda, MD; Available from: https://seer.cancer.gov/csr/1975_2017/
5. Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196:1021–9 Amended in 2020, this article reports the current American Urological Association guidelines for diagnosis and treatment of non-muscle-invasive bladder cancer.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献